Great West Life Assurance CO Amphastar Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$57.4 Billion
Q3 2024

A detailed history of Great West Life Assurance CO transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 36,947 shares of AMPH stock, worth $1.36 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

36,947

Previous 49,122 24.79%

Holding current value

$1.36 Million

Previous $1.97 Million 8.8%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$36.99 - $50.09 $450,353 - $609,845	-12,175 Reduced 24.79%	36,947 $1.79 Million
Q2 2024 Aug 12, 2024	BUY	$38.65 - $43.48 $355,270 - $399,668	9,192 Added 23.02%	49,122 $1.97 Million
Q1 2024 May 13, 2024	BUY	$42.85 - $63.45 $387,235 - $573,397	9,037 Added 29.25%	39,930 $1.75 Million
Q4 2023 Feb 13, 2024	SELL	$44.49 - $62.93 $107,843 - $152,542	-2,424 Reduced 7.28%	30,893 $1.91 Million
Q3 2023 Nov 14, 2023	BUY	$45.51 - $65.0 $35,497 - $50,700	780 Added 2.4%	33,317 $1.53 Million
Q2 2023 Aug 10, 2023	SELL	$35.77 - $58.38 $105,628 - $172,396	-2,953 Reduced 8.32%	32,537 $1.87 Million
Q1 2023 May 12, 2023	SELL	$27.99 - $37.92 $69,275 - $93,852	-2,475 Reduced 6.52%	35,490 $1.33 Million
Q4 2022 Feb 10, 2023	SELL	$27.93 - $31.27 $122,947 - $137,650	-4,402 Reduced 10.39%	37,965 $1.06 Million
Q3 2022 Nov 01, 2022	BUY	$27.56 - $37.75 $1.17 Million - $1.6 Million	42,367 New	42,367 $1.19 Million
Q2 2022 Aug 09, 2022	BUY	$29.79 - $42.29 $155,980 - $221,430	5,236 Added 16.22%	37,512 $1.3 Million
Q1 2022 May 12, 2022	SELL	$22.96 - $36.45 $4,936 - $7,836	-215 Reduced 0.66%	32,276 $1.19 Million
Q4 2021 Feb 14, 2022	SELL	$18.14 - $23.29 $3,682 - $4,727	-203 Reduced 0.62%	32,491 $756,000
Q3 2021 Nov 15, 2021	BUY	$17.83 - $21.49 $40,010 - $48,223	2,244 Added 7.37%	32,694 $627,000
Q1 2021 May 17, 2021	SELL	$17.21 - $20.65 $83,348 - $100,007	-4,843 Reduced 13.72%	30,450 $557,000
Q4 2020 Feb 16, 2021	SELL	$17.76 - $21.24 $92,636 - $110,787	-5,216 Reduced 12.88%	35,293 $710,000
Q3 2020 Nov 17, 2020	SELL	$17.99 - $22.22 $597,807 - $738,370	-33,230 Reduced 45.06%	40,509 $759,000
Q3 2020 Nov 13, 2020	BUY	$17.99 - $22.22 $582,983 - $720,061	32,406 Added 78.4%	73,739 $1.38 Million
Q2 2020 Aug 17, 2020	SELL	$14.25 - $22.46 $32,162 - $50,692	-2,257 Reduced 5.18%	41,333 $927,000
Q1 2020 May 14, 2020	BUY	$12.66 - $20.08 $6,393 - $10,140	505 Added 1.17%	43,590 $642,000
Q4 2019 Feb 11, 2020	BUY	$17.07 - $20.64 $735,460 - $889,274	43,085 New	43,085 $831,000
Q3 2019 Oct 25, 2019	SELL	$19.12 - $22.62 $888,372 - $1.05 Million	-46,463 Closed	0 $0
Q1 2019 May 08, 2019	BUY	$19.46 - $25.28 $50,596 - $65,728	2,600 Added 5.93%	46,463 $949,000
Q1 2018 May 10, 2018	SELL	$17.23 - $20.35 $42,627 - $50,345	-2,474 Reduced 5.34%	43,863 $822,000
Q3 2017 Nov 09, 2017	BUY	$14.73 - $17.99 $682,544 - $833,602	46,337	46,337 $828,000

Others Institutions Holding AMPH

# of Institutions

286

Shares Held

34.9M

Call Options Held

74.3K

Put Options Held

22.3K

View Full List

About Amphastar Pharmaceuticals, Inc.

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.81B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

More about AMPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Amphastar Pharmaceuticals, Inc. Transaction History